Editorial: Reviews in opioid use disorders von Walwyn, Wendy, Evoy, Kirk E

Volltext

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern? von Peckham, Alyssa M, Evoy, Kirk E, Ochs, Leslie, Covvey, Jordan R

Volltext

Abuse and Misuse of Pregabalin and Gabapentin von Evoy, Kirk E., Morrison, Megan D., Saklad, Stephen R.

Volltext

Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update von Evoy, Kirk E., Sadrameli, Sarvnaz, Contreras, Jillian, Covvey, Jordan R., Peckham, Alyssa M., Morrison, Megan D.

Volltext

Kratom as a potential substance use disorder harm reduction agent von Green, MeShell, Vadiei, Nina, Veltri, Charles A, Grundmann, Oliver, Evoy, Kirk E

Volltext

Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics von Evoy, Kirk E, Teng, Chengwen, Encarnacion, Victor G, Frescas, Brian, Hakim, John, Saklad, Stephen, Frei, Christopher R

Volltext

Quetiapine and olanzapine misuse prevalence in a US general population sample von Evoy, Kirk E, Humpert, Shelby, Torrez, Sorina, Hussein, Haneen, Covvey, Jordan R

Volltext

Naloxone Accessibility Without a Prescriber Encounter Under Standing Orders at Community Pharmacy Chains in Texas von Evoy, Kirk E, Hill, Lucas G, Groff, Lindsey, Mazin, Lubna, Carlson, Christian C, Reveles, Kelly R

Volltext

Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability von Evoy, Kirk E., Peckham, Alyssa M., Covvey, Jordan R., Tidgewell, Kevin J.

Volltext

Pharmacist counseling when dispensing naloxone by standing order: A secret shopper study of 4 chain pharmacies von Contreras, Jillian, Baus, Courtney, Brandt, Claire, Witry, Matthew, Peters, Joanne, Evoy, Kirk E.

Volltext

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids von Desai, Payal H., Taylor, Olesya, Shah, Kunal J., Evoy, Kirk E., Peckham, Alyssa M.

Volltext

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA von Hill, Lucas G., Loera, Lindsey J., Evoy, Kirk E., Renfro, Mandy L., Torrez, Sorina B., Zagorski, Claire M., Perez, Joshua C., Jones, Shaun M., Reveles, Kelly R.

Volltext

Receipt of Substance Use Counseling Among Ambulatory Patients Prescribed Opioids in the United States von Evoy, Kirk E, Leonard, Charles E, Covvey, Jordan R, Ochs, Leslie, Peckham, Alyssa M, Soprano, Samantha, Reveles, Kelly R

Volltext

Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS) von Evoy, Kirk E., Covvey, Jordan R., Peckham, Alyssa M., Ochs, Leslie, Hultgren, Kyle E.

Volltext

State-Level Approaches to Expanding Pharmacists’ Authority to Dispense Naloxone May Affect Accessibility von Hill, Lucas G, Reveles, Kelly R, Evoy, Kirk E

Volltext

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states von Hill, Lucas G., Loera, Lindsey J., Torrez, Sorina B., Puzantian, Talia, Evoy, Kirk E., Ventricelli, Daniel J., Eukel, Heidi N., Peckham, Alyssa M., Chen, Clement, Ganetsky, Valerie S., Yeung, Megan S., Zagorski, Claire M., Reveles, Kelly R.

Volltext

Impact of student pharmacist–led naloxone academic detailing at community pharmacies in Texas von Evoy, Kirk E., Groff, Lindsey, Hill, Lucas G., Godinez, William, Gandhi, Ravi, Reveles, Kelly R.

Volltext

Suvorexant: A Dual Orexin Receptor Antagonist for the Treatment of Sleep Onset and Sleep Maintenance Insomnia von Patel, Kunal V., Aspesi, Anthony V., Evoy, Kirk E.

Volltext

Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample von Evoy, Kirk E., Covvey, Jordan R., Peckham, Alyssa M., Reveles, Kelly R.

Volltext

Authors’ Reply to Bonnet et al. “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update” von Evoy, Kirk E., Sadrameli, Sarvnaz, Contreras, Jillian, Covvey, Jordan R., Peckham, Alyssa M.

Volltext